ConFlow MedTech

ConFlow MedTech has always been dedicated to the research, development, production, and industrial operation of innovative cardiovascular medical devices. By continuously conducting independent research and clinically transforming cutting-edge high technologies, it aims to become a world-class innovative product manufacturer with international influence. The ConFlow MedTech management team has over a decade of deep expertise in the structural heart disease field, consisting of seasoned experts in project R&D, production, clinical quality registration, and market sales. The company has applied for more than twenty PCT, invention, and utility model patents. Its headquarters is located in Songjiang Technology City, under the Shanghai Lingang Group, with a 2,200-square-meter Class 10,000 cleanroom, advanced laboratories, machining platforms, and office spaces. Currently, in addition to its shunt device project, which has entered the clinical trial stage, the company's innovative congenital heart intervention products and valve products have also moved into the animal experiment exploration phase, striving to build a differentiated and innovative structural heart disease R&D and production platform.